Robert Korngold on Advances in Bone Marrow Transplant

Robert Korngold, PhD
Published: Saturday, Feb 25, 2017



Robert Korngold, PhD, chief of The Division of Research at John Theurer Cancer Center, reflects on the progress made in the field of bone marrow transplant. Most strikingly, new approaches have opened the opportunity of a bone marrow transplant to virtually all eligible patients, he noted.

Bone marrow transplants have become the platform from which immunotherapy and vaccines can be built, Korngold believes. New methods and approaches are becoming available, which lend strength to the graph versus tumor response in the hope of avoiding relapses and complications.

<<< View more from the 2017 BMT Tandem Meetings


Robert Korngold, PhD, chief of The Division of Research at John Theurer Cancer Center, reflects on the progress made in the field of bone marrow transplant. Most strikingly, new approaches have opened the opportunity of a bone marrow transplant to virtually all eligible patients, he noted.

Bone marrow transplants have become the platform from which immunotherapy and vaccines can be built, Korngold believes. New methods and approaches are becoming available, which lend strength to the graph versus tumor response in the hope of avoiding relapses and complications.

<<< View more from the 2017 BMT Tandem Meetings

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Addressing Post-Transplant Obstacles: Current and Emerging Strategies to Evolve the Standard of Care for Patients With Graft-Versus-Host DiseaseMar 28, 20192.0
2017 Year in Review™: Clinical Impact of Immunotherapies in the Treatment of CancerMar 30, 20191.75
Publication Bottom Border
Border Publication
x